Fasenra 30 mg solution for injection in pre filled syringe

Product Information *

  • Company:

    AstraZeneca Pharmaceuticals (Ireland) DAC
  • Status:

    Updated
  • Active Ingredients :

    This medicinal product is subject to additional monitoring.

    *Additional information is available upon request

  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 15 July 2021

File name

20210708 SPC IE MT Fasenra PFS and PFP MELTEMI Update RSP 21 0008_1626348587.pdf

Reasons for updating

  • Change to section 4.8 - Undesirable effects

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 31 March 2021

File name

20210326 Package Leaflet IE MT Fasenra PFS 30 mg Nijmegen Change RSP 21 0003_1617204037.pdf

Reasons for updating

  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision

EDM Updated on 22 July 2020

File name

20200716 IFU IE MT Fasenra 30 mg PFS Integrated Carton Update RSP 20 0015_1595411547.pdf

Reasons for updating

  • Replace File

EDM Updated on 16 July 2019

File name

20190627-uim-ifu-Fasenra-PFS SA only-RSP 19 0040_1562659381.pdf

Reasons for updating

  • Add New Doc

Updated on 09 July 2019

File name

20190627-uim-pl-Fasenra-PFS SA only-RSP 19 0036_1562659336.pdf

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 3 - how to take/use
  • Change to section 3 - overdose, missed or forgotten doses
  • Change to section 5 - how to store or dispose
  • Change to section 6 - what the product contains
  • Change to section 6 - date of revision

Updated on 09 July 2019

File name

20190627-uim-spc-Fasenra-PFS SA and AI-RSP 19 0039_1562659223.pdf

Reasons for updating

  • Change to section 1 - Name of medicinal product
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 3 - Pharmaceutical form
  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 6.4 - Special precautions for storage
  • Change to section 6.5 - Nature and contents of container
  • Change to section 6.6 - Special precautions for disposal and other handling
  • Change to section 8 - Marketing authorisation number(s)
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 14 June 2019

File name

20190529-uim-spc-Fasenra-BORA-RSP 19 0026_1560499823.pdf

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.8 - Undesirable effects
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 02 April 2019

File name

20190328-uim-pl-Fasenra-brexit-RSP 19 0013 NO MIL_1554211315.pdf

Reasons for updating

  • Change to section 6 - manufacturer

Updated on 01 April 2019

File name

20190315-uim-pl-Fasenra-anaphylaxis-RSP 19 0010 NO MIL_1553851177.pdf

Reasons for updating

  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 29 March 2019

File name

20190315_uim_spc_Fasenra_anaphylaxis_RSP_19_0009_1553851305.pdf

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 21 March 2019

File name

20180108-Package Leaflet-uim-Fasenra-initial-RSP 17 0132_NO MIL_1553187067.pdf

Reasons for updating

  • New PIL for medicines.ie

Updated on 20 March 2019

File name

20180108-Package Leaflet-uim-Fasenra-initial-RSP 17 0132_1553098694.pdf

Reasons for updating

  • New PIL for new product

Updated on 20 March 2019

File name

20190214_SmPC-uim-Fasenra-Type II ALIZE-RSP 19 0003_1553099929.pdf

Reasons for updating

  • New SPC for medicines.ie

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 20 March 2019

File name

20190214_SmPC-uim-Fasenra-Type II ALIZE-RSP 19 0003_1553098727.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may not be renewed (A)